Eko SENSORA for Detecting Heart Murmurs

This study is testing a device called Eko Sensora in the emergency department. This device is a digital stethoscope that uses artificial intelligence (AI) to listen to your heart sounds and identify any abnormalities, specifically heart murmurs. You might be able to join if you are 18 or older and come to the emergency department with symptoms like chest pain, shortness of breath, or fainting. If you have weakness as a main symptom, you might be eligible if you are over 50 and have certain health conditions. The study aims to see how well the Eko Sensora can find new, important heart murmurs by the end of the study, which is about 90 days.

Study design
This is an interventional study planning to enroll 300 participants.
What's involved
The exam involves placing the stethoscope in four areas on your chest for 15-30 seconds each until a green light appears, indicating a useful recording.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint is measured through study completion, an average of 90 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06155643

EKO SENSORA: Detecting Clinically Significant Murmurs

Recruiting
NAAges 18+InterventionalScreening
Corewell Health South
~300 participants
Updated 2026-07-20 on ClinicalTrials.gov
What's tested:Eko Sensora

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of new clinically significant heart murmurs detected
Measured over through study completion, an average of 90 days
Heart Murmurs
1 sites across 1 states
Michigan1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Chief complaint of chest pain, shortness of breath, difficulty breathing, or syncope/near-syncope.
Patients with chief complaint of Weakness would be eligible if over the age of 50 and have a history of at least two of hypertension, BMI\>/= 30, diabetes, hyperlipidemia, atrial fibrillation, heart attack, stroke/Transient ischemic attack, prior cardiac surgery or angiography

Exclusion

Contact isolation patients
Pediatric patients under the age of 18
  • Number of new clinically significant heart murmurs detectedthrough study completion, an average of 90 days